AN EXPERIMENTAL DESIGN APPROACH FOR OPTIMIZATION OF MODIFIED COLORIMETRIC FIRST-ORDER DERIVATIVE METHOD FOR ESTIMATION OF SERRALYSIN IN BULK AND PHARMACEUTICAL FORMULATION

Authors

  • Kulkarni Manasi B PhD Scholar, Ponnaiyah Ramajayam Institute of Science and Technology University, Thanjavur, Tamil Nadu, India,
  • Joshi Anagha M Principal, SCES’S Indira College of Pharmacy, Pune, Maharashtra, India.

DOI:

https://doi.org/10.22159/ajpcr.2018.v11i9.26999

Keywords:

Serralysin, Experimental design, Nil, Colorimetric, First-order derivative, Biuret, Nil

Abstract

Objective: The aim of the present work is to use experimental design to screen and optimize experimental variables for developing a colorimetric first-order derivative method for determining content of serralysin (SER) using biuret and Folin–Ciocalteu phenol reagent for stable color development. The method is based on the reaction of peptide bond in the protein with Biuret reagent in alkaline medium and further reaction of remaining tryptophan and tyrosine residues with Folin–Ciocalteu Phenol reagent to form a stable blue-colored complex (first-order derivative λmax 620 nm).

Materials and Methods: A two-level full factorial design was utilized to screen the effect of Volume of NaOH (A), volume of biuret reagent (B), volume of Folin–Ciocalteu phenol reagent (C), and concentration of NaOH (D) on the formation of blue-colored SER - reagent complex (response - absorbance). A box Behnken experimental design with response surface methodology was then utilized to evaluate the main interaction and quadratic effects of these factors on the selected response.

Results: With the help of a response surface plot and contour plot, the optimum values of the selected factors were determined and used for further experiments. These values were volume of NaOH (A) of 1.0 mL, volume of biuret reagent (B) of 0.25 mL, and volume of Folin–Ciocalteu phenol reagent (C) of 10 μL. The proposed method was validated according to the ICH Q2(R1) method validation guidelines. The developed colorimetric first-order derivative method was found to be simple, accurate, rapid, sensitive, precise, and economic. Further optimization of the method with experimental design approach makes it convenient for use in laboratory.

Conclusion: The results of present study have clearly shown that an experimental design approach may be effectively applied to the optimization of a modified visible spectrophotometric method for estimation of SER in bulk and in pharmaceutical formulation with the least number of experimental runs possible. The method can be employed successfully for the estimation of SER in both bulk and tablet dosage form.

 

Downloads

Download data is not yet available.

References

Lotfy HM, Saleh SS. Recent development in ultraviolet spectrophotometry through the last decade (2006–2016): A review. Int J Pharm Pharm Sci 2016;8:40-56.

Tiwari M. The role of Serralysin in the resolution of inflammation. Asian J Pharm Sci 2017;12:209-15.

Nakamura S, Hashimoto Y, Mikami M, Yamanaka E, Soma T, Hino M, et al. Effect of the proteolytic enzyme serrapeptase in patients with chronic airway disease. Respirology 2003;8:316-20.

Jadhav ML, Tambe SR, Girase MV. Analytical quality by design approach for development of UV spectrophotometric methods in the estimation of trospium chloride from capsule dosage form. Int J Pharm Pharm Sci 2014;6:530-3.

Anderson MJ, Whitcomb PJ. DOE Simplified-Practical Tools for Effective Experimentation. 3rd ed. Taylor and Francis Group: CRC Press; 2015.

Ferreira SL, Bruns RE, Ferreira HS, Matos GD, David JM, Brandão GC, et al. Box-behenken design: An alternative for the optimization of analytical methods. Anal Chim Acta 2007;597:179-86.

Bezerra MA, Santelli RE, Oliveira EP, Villar LS, Escaleira LA. Response surface methodology (RSM) as a tool for optimization in analytical chemistry. Talanta 2008;76:965-77.

Wani YB, Patil DD. An experimental design approach for optimization of spectrophotometric method for estimation of cefiximetrihydrate using ninhydrin as derivatizing reagent in bulk and pharmaceutical formulation. J Saudi Chem Soc 2017;21:S101-11.

Anderson MJ, Whitcomb PJ. RSM Simplified-Optimizing Processes using response Surface Methods for Design of Experiments. Special Indian Edition. Taylor and Francis Group: CRC Press; 2016.

Box GP, Behenken DW. Some new three level designs for the study of quantitative variables. Technometrics 1960;2:455-75.

Patravale VB, Disouza JI, Rustomjee MT. Pharmaceutical Product Development. Taylor and Francis Group: CRC Press; 2016.

Gupte V, Luthra U. Analytical techniques for Serralysin - A review. J Pharm Anal 2017;7:203-7.

Kyoko T, Keiko M, Kayoko S. Quality tests of high molecular weight substances by chromatography. ByoinYakugaku 1981;6:233-7.

Ananthkrishnan A, Ramesh B, Muthuraman MS. Optimization studies in the production and purification of Serralysin from Serratia marcescens UV mutant SM3. Int J Pharm Pharm Sci 2013;5:748-52.

Kazuyuki S, Yoshifumi M, Etsuko M. Application of X-Ray powder diffractionto drug information and dispensing services. II. Identification of ingredients in powder preparations containing composite powder like granules and pulverized tablets (or capsules). Byoin Yakugaku 1992;18:700-9.

Tariq AL, Reyaz AL, Prabakaran JJ. Purification and characterization of 56 KDa cold active protease from Serratia marcescens. Afr J Microbiol Res 2011;5:5841-7.

Abou EM. Purification and characterization of protease produced by Pseudomonas aeruginosa, Egypt. J Microbiol 1997;31:323-35.

Salamone PR, Wodzinski RJ. Production, purification and characterization of a 50-kDa extracellular metalloprotease from Serratia marcescens. Appl Microbiol Biotechnol 1997;48:317-24.

Zeng W, Chen L, Deng Z. Determination of enzymic activity of serralysin in seradase enterosoluble tablets. Guangdong Yaoxueyuan Xuebao 1997;13:81-3.

Pansuriya RC, Singhal RS. Evolutionary operation (EVOP) to optimize whey independent serralysin production from Serratia marcescens NRRL B-23112. J Microbiol Biotechnol 2010;20:950-7.

Mali N, Wavikar P, Vavia P. Serratiopeptidase loaded chitosan nanoparticles by polyelectrolyte complexation: In vitro and in vivo evaluation. AAPS PharmSciTech 2015;16:59-66.

Maheshwari M, Miglani G, Mali A, Paradkar A, Yamamura S, Kadam S. Development of tetracycline-serratiopeptidase-containing periodontal gel: Formulation and preliminary clinical study. AAPS PharmSciTech 2006;7:76.

Singh KP, Chhabra G, Sharma V, Pathak K. Thermosensitive periodontal sol of ciprofloxacin hydrochloride and serratiopeptidase: Pharmaceutical and mechanical analysis. Int J Pharm Investig 2014;4:5-14.

Nirale NM, Menon MD. Topical formulations of serratiopeptidase: Development and pharmacodynamic evaluation. Indian J Pharm Sci 2010;72:65-71.

Shinde UA, Kanojiya SS. Serralysin niosomal gel with potential in topical delivery. J Pharm (Cairo) 2014;2014:1-9.

Doerr M, Traub WH. Purification and characterization of two Serratia marcescens proteases, zentralblatt fuer bakteriologie, mikrobiologie und hygiene, series A: Medical microbiology, infectious diseases, virology. Parasitology 1984;257:6-19.

Dominique L, Markus K, Jean W. Spectrophotometric assay for amidolytic activity of alkaline protease from Pseudomonas aeruginosa. Anal Chim Acta 1997;345:219-25.

Pandya EJ, Kapupara P, Shah KV. Development and validation of simultaneous estimation of diclofenac potassium, paracetamol and serratiopeptidase by first order derivative UV spectroscopy method in pharmaceutical formulation. J Chem Pharm Res 2014;6:912-24.

Patel RA, Joshi SH. Development and validation of spectrophotometric methods for simultaneous estimation of diclofenac sodium and serratiopeptidase in pharmaceutical dosage form. World J Pharm Pharm Sci 2014;3:1279-91.

Parmar AR, Bhakhar DN, Shah DK, Vekariya KV. Simultaneous estimation of aceclofenac and serratiopeptidase in tablet dosage form by absorbance ratio method using visible spectrophotometry. Pharm Sin 2012;3:321-6.

Singh D, Saraf S, Dixit VK, Singh D, Singh M. Spectrophotometric determination of serratiopeptidase and Metronidazole in combined dosage. Biosci Biotech Res Asia 2007;4:305-6.

Rakibe VD, Kapse SN, Mahajan S. Simultaneous estimation of serratiopeptidase and diclofenac sodium by UV spectrophotometric method. J Curr Pharm Res 2014;4:1297-301.

Limbasiya AB, Kapupara PP, Shah K. Development and validation of analytical method for simultaneous estimation of diclofenac potassium and serratiopeptidase in pharmaceutical formulation. Res J Pharm Technol 2014;7:655-9.

Daharwal SJ, Saraf S. Derivative spectrophotometric method for simultaneous estimation of nimesulide and Serralysin from tablet dosage form. Anal Chem Indian J 2007;5:137-40.

Rawat M, Saraf S. Influence of selected formulation variables on the preparation of enzyme-entrapped eudragit S100 microspheres. AAPS PharmSciTech 2007;8:289-97.

Hiroshi M, Kazuyuki M. Serralysin and related bacterial proteinases. Methods Enzymol 1995;248:395-413.

Yoshiyuki T, Yuki O, Yuya Y. Development of a highly sensitive enzyme immunoassay for serrapeptase and its accuracy. Seibutsu Shiryo Bunseki 2010;33:260-6.

Louis D, Sorlier P, Wallach J. Quantitation and enzymatic activity of the alkaline protease from Pseudomonas aeruginosa in culture supernatants from clinical strains. Clin Chem Lab Med 1998;36:295-8.

Moriya N, Nakata M, Nakamura M, Takaoka M, Iwasa S, Kato K, et al. Intestinal absorption of serrapeptase (TSP) in rats. Biotechnol Appl Biochem 1994;20:101-8.

Miyata K, Tsuda M, Tomoda K. Determination of serratia protease by radioimmunoassay. Anal Biochem 1980;101:332-28.

Mathew ST, Devi SG, Sandhya KV. Quantitation of serrapeptase in formulations by UV method in the microplate format. Curr Drug Deliv 2008;5:303-5.

Koyama H, Ikemoto T, Itoh S, Hirai S, Kitamori N. Pharmaceutical determination of serrapeptase by high-performance liquid chromatography using gel filtration column. Takeda Kenkyushoho 1989;48:72-7.

Louis D, Bernillon J, Paisse JO, Wallach JM. Use of liquid chromatography-mass spectrometry coupling for monitoring the serratiopeptidase-catalyzed hydrolysis of a peptide library. J Chromatogr B 1999;732:271-6.

Kingsley GR. The direct biuret method for the determination of serum proteins as applied to photoelectric and visual colorimetry. J Lab Clin Med 1942;27:840.

Mehl JW. The biuret reaction of proteins in the presence of ethylene glycol. J Biol Chem 1944;157:173.

Weichselbaum TE. An accurate and rapid method for the determination of proteins in small amounts of blood serum and plasma. Am J Clin Pathol 1946;10:40-9.

Gornall AG, Bardawill CJ, David MM. Determination of serum proteins by means of the biuret reaction. J Biol Chem 1949;177:751-66.

Folin O, Ciocalteu V. On tyrosine and tryptophane determinations in proteins. J Biol Chem 1927;73:627-50.

Hesin WU. Contribution to the chemistry of phosphomolybdic acids, phosphotungstic acids and allied substances. J Biol Chem 1920;43:189.

Ohnishi ST, Barry JK. A simplified method of quantitating protein using the biuret and phenol reagents. Anal Biochem 1978;86:193-200.

Published

07-09-2018

How to Cite

B, K. M., and J. Anagha M. “AN EXPERIMENTAL DESIGN APPROACH FOR OPTIMIZATION OF MODIFIED COLORIMETRIC FIRST-ORDER DERIVATIVE METHOD FOR ESTIMATION OF SERRALYSIN IN BULK AND PHARMACEUTICAL FORMULATION”. Asian Journal of Pharmaceutical and Clinical Research, vol. 11, no. 9, Sept. 2018, pp. 293-00, doi:10.22159/ajpcr.2018.v11i9.26999.

Issue

Section

Original Article(s)